1-3 of 3
Lade Adewale
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of CPX-351 Plus Venetoclax in Patients with Relapsed/Refractory (R/R) or Newly Diagnosed Acute Myeloid Leukemia (AML)

Kunhwa Kim, Hagop Kantarjian, Gautam Borthakur, Koichi Takahashi, Nicholas J. Short, Courtney D. DiNardo, Elias J. Jabbour, Kelly S. Chien, Naval Daver, Naveen Pemmaraju, Nitin Jain, Lade Adewale, Guillermo Montalban-Bravo, William G. Wierda, Srdan Verstovsek, Marina Konopleva, Farhad Ravandi, Tapan M. Kadia
Journal: Blood
Blood (2021) 138 (Supplement 1): 1275.
https://doi.org/10.1182/blood-2021-154148
Published: 2021
Journal Articles

A Phase Ib Pilot Study of Itacitinib Combined with Alemtuzumab in Patients with T-Cell Prolymphocytic Leukemia (T-PLL)

Tapan M. Kadia, Farhad Ravandi, Gautam Borthakur, Musa Yilmaz, Guillermo Montalban-Bravo, Lade Adewale, Sherry A. Pierce, Nitin Jain, Alessandra Ferrajoli, William G. Wierda, Hagop Kantarjian
Journal: Blood
Blood (2021) 138 (Supplement 1): 1375.
https://doi.org/10.1182/blood-2021-153691
Published: 2021
Journal Articles

Phase II Study of CPX-351 Plus Venetoclax in Patients with Acute Myeloid Leukemia (AML)

Tapan M. Kadia, MD, Gautam Borthakur, MD, Koichi Takahashi, MD PhD, Courtney D. DiNardo, MD MSCE, Naval Daver, MD, Naveen Pemmaraju, MD, Elias Jabbour, MD, Nitin Jain, MD, Nicholas J. Short, MD, Wei Qiao, PhD, Lade Adewale, Caitlin R. Rausch, PharmD, Sherry A. Pierce, BSN, BA, Yesid Alvarado, MD, Amin M. Alousi, MD, Uday R. Popat, MD, Issa F. Khouri, MD, Guillermo Garcia-Manero, MD, Marina Konopleva, MD PhD, Jorge E. Cortes, MD, Farhad Ravandi, MBBS, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–22.
https://doi.org/10.1182/blood-2020-142074
Published: 2020